-
Natural History of Movement Abnormalities on Hereditary Spastic Paraplegia: validation of timed functional instruments
-
NBIA-like MRI findings in a patient with Huntington’s disease
-
Need of next generation sequencing technology to de-convolute autosomal recessive cerebellar ataxias in India
-
Negative and Positive Feedback Processing in Parkinson’s Disease and Impulse Control Disorder: an ERP Study
-
Network localization of cervical dystonia based on causal brain lesions
-
Neural correlates of compensatory process and impaired working memory in Parkinson’s disease during disease progression
-
Neural correlates of Level-1 and Level-2 diagnostic criteria for Mild Cognitive Impairment in Parkinson´s disease.
-
Neural correlates of visual cues for gait impairment in Parkinson’s disease: a preliminary analysis
-
Neural plasticity based on the change of the glutamate receptors: Repetition of electrical stimulation for the reduction of Parkinsonian symptoms
-
Neuritic pathology in Parkinson’s Disease results from loss of anti-oxidant response activity
-
Neuroanatomical and clinical predictors of pain in patients with early de novo Parkinson’s disease
-
Neuroanatomical and Electrocortical Networks correlates in Parkinson’s Disease Patients with Mild Cognitive Impairment:The PaCoS Study
-
Neuroanatomical correlates of early cognitive change in Parkinson’s disease
-
Neuroart: A Hummingbird in the Cage of the Brain
-
Neurocognitive changes after STN-DBS among PD patients – a 2-year follow-up study in Hong Kong
-
Neurocognitive changes post-bilateral globus pallidus interna DBS for Parkinson’s disease with autologous sural nerve graft to the substantia nigra or nucleus basalis of Meynert
-
Neurofascin is a novel gene associated with autosomal recessive spastic and polyneuropathy
-
Neurofeedback-guided motor imagery in Parkinson’s disease
-
Neuroimaging in Parkinson’s disease dementia: Connecting the dots
-
Neuroinflammation and activation of Zif-268 in dyskinetic 6-OHDA-lesioned rats is counteracted by association of a 5-HT1A/1B receptor agonist and an A2A receptor antagonist
-
Neurological complications secondary to metronidazole: Case Report
-
Neurological Wilson Disease: Clinical Aspects and Evolution in 10 Cases
-
Neurology Residents Versus a Mobile Medical Application in deducing differential diagnoses in Movement Disorders: A multi-center, cross-sectional, observational study
-
Neuromelamin-MRI in patients with Pure Autonomic Failure
-
Neuromelanin MRI detects monoaminergic cell loss in Huntington Disease Expansion Gene Carriers.
-
Neuromodulatory potentials of revasterol and Carpogon capitatus Roxb on the rat brain: Novel approach for Parkinson’s diseases
-
Neuromuscular electrical stimulation for the treatment of jaw-closing dystonia
-
NEURONAL NETWORK UNDERLYING DYSPHAGIA IN PARKINSON’S DISEASE
-
Neuronal Network Underlying Speech Difficulties in Parkinson’s Disease
-
Neuropathological findings in a SPG4 gene mutation carrier
-
Neuropathology in a case of HD-like syndrome caused by mutations in RNF216
-
Neuropathy in patients treated with LCIG in the Czech and the Slovak Republic
-
Neurophysiologic characterization of Re-emergent tremor (RET) in Parkinson’s disease
-
Neuroprotective actions of red propolis extract and formononetin in a rat model of Parkinson’s disease
-
Neuroprotective and neurotrophic efficacy of Ginkgo biloba extracts against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease
-
Neuroprotective effect of crocus sativus in lead-induced dopaminergic neurotoxicity in Meriones shawi: A possible link with Parkinson’s disease
-
Neuroprotective effect of Lemon oil on 6-OHDA-Induced Apoptosis in PC12 Cells through the ROS-NO Pathway
-
Neuroprotective effect of Yerba mate (Ilex paraguariensis) in a Drosophila model of Parkinson ’s disease
-
Neuroprotective Effects of Combined Administration of Coenzyme Q10 and Vitamin-E in Chronic Cerebral Hypoperfusion-Induced Neurodegeneration in Rats
-
Neuropsychiatric clusters in patients with Parkinson’s disease and their clinical and demographic correlates
-
Neuropsychiatric manifestations in Parkinson’s disease
-
NEUROPSYCHIATRIC SYMPTOMS IN EARLY TO ADVANCED PATIENTS WITH THE RICHARDSON’S SYNDROME VARIANT OF PROGRESIVE SUPRANUCLEAR PALSY
-
Neuropsychological and behavioral profile of patients with isolated REM sleep behaviour disorders (iRBD) and patients with RBD associated with Parkinson’s Disease (PDRBD)
-
Neuropsychological changes over the first 6 years of Parkinson’s disease in the ICICLE-PD cohort
-
Neuropsychological differences between patients with Parkinson’s Disease and Essential Tremor
-
Neuropsychological profile of patients with functional movement disorders
-
Neuroradiological differences between patients with akinesia-dominant and tremor-dominant Parkinson’s disease
-
New epidemiological data of Parkinson’s Disease in Ukraine
-
New Neuropathological Staging System for Lewy Body Disease
-
Nigral Iron Load as Diagnostic Parameter in Parkinson’s Disease
-
Nigrostriatal degeneration in DYT-PRKRA: new insights on a rare disorder
-
NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced Parkinson’s Disease: Study Design and Status Update
-
NKX2-1-Related Disorder with Cerebral Folate Deficiency
-
No difference in balance and gait parameters of the patients with akinetic-rigid and tremor-dominant Parkinson’s disease
-
No evidence for early emotional processing in the subthalamic nucleus – a single neuron study
-
No link between striatal dopaminergic axons and dopamine transporter imaging in Parkinson’s disease
-
Nocturnal stridor in multiple system atrophy: video-polysomnography and clinical features
-
Non motor fluctuations in Parkinson’s disease: Findings from a Tunisian cohort
-
Non motor symptoms Parkinson’s disease
-
Non-CpG methylation in the FXN gene in patients with Friedreich’s ataxia
-
Non-Invasive Vagus Nerve Stimulation: A non-pharmacological approach to target gait impairment in Parkinson’s disease?
-
Non-Medical Switching: Impact on Movement Disorders Patients’ Access and Care
-
Non-motor symptoms and risk of functional dependency in early Parkinson’s disease
-
Non-motor symptoms burden grading in Parkinson disease with the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS)
-
Non-motor symptoms burden is greater in early Parkinson’s disease patients with motor complications
-
Non-motor symptoms contribute to the caregiver burden in Progressive Supranuclear Palsy
-
Non-motor Symptoms in Hyperkinetic Movement Disorders
-
Non-motor symptoms in Myoclonus-Dystonia: a comparison to other dystonia subtypes
-
Non-motor symptoms in Parkinson disease motor subtypes: a study using the new MDS-NMS
-
Non-Motor Symptoms in Patients with Parkinson’s Disease: Effect of Gender, Disease Severity, and Disease Phenotype
-
Nonmotor Symptoms in Parkinson’s Disease: 36-month Follow-up Study Comparing Bilateral Subthalamic Stimulation and Standard-of-care Medication
-
Normative Curves for Selected Unified Huntington Disease Rating Scale Measures
-
Normative Reference for Timed Up and Go Test (TUG) in Young Indian Adults- Preliminary Results
-
Novel compound heterozygous mutations in the TSFM gene causes childhood-onset chorea
-
Novel exploratory outcome assessments in GENERATION HD1
-
Novel familial HPCA mutation associated with autosomal recessive dystonia: Strengthening the role of HPCA in hereditary movement disorders.
-
Novel Mutation of NUS1 Gene Presenting With Developmental And Epileptic Encephalopathy and Movement Disorders
-
Novel p.Pro193Arg missense mutation in ABCD1-gene associated with phenotype of ALD/AMN: a case report
-
Nrf2 pathway in patients with Parkinson’s disease
-
NS-PARK cohort: a nationwide real life longitudinal cohort of PD patients
-
Number of people with Parkinson’s dementia in New Zealand
-
Nutritional status in patients with Parkinson’s disease and its relationship with the motor phenotype.
2019 International Congress
September 22-26, 2019. Nice, France.